strong organ growth brokerag
strong organ growth corpor brokerag ep beat
ajg result per share best forecast consensu due
better result brokerag corpor segment brokerag earn
nickel higher expect organ growth better expect
margin point higher expect corpor earn better
expect aid clean energi result risk manag ep match forecast
commission/fe organ growth brokerag segment beat
forecast organ growth volatil howev base current trend
manag commentari regard market condit ajg initi
increas confid forecast look organ growth
remaind year modestli previou project conserv
assum first half organ growth sustain assum compani
continu activ acquir
rais estim reflect beat quarter
expect revenu recent acquisit due healthi organ growth
continu model modest ebitdac margin improv brokerag segment
similar chang result modest increas forecast per share
nickel increas project per share
rais po
rais price object po base
cash ep previous expect continu healthi organ
growth brokerag segment favor comment insur
carrier regard direct price increas confid outlook
allow us use higher multipl oper leverag allow on-going margin
improv lead double-digit ep growth support higher price-to-earnings multipl
view compani ampl flexibl continu enhanc oper
acquisit reiter buy rate
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
arthur gallagh world fourth-largest
risk manag servic via network
subsidiari place p/c reinsur surplu
line manag employe benefit program
risk manag servic perform
manag loss control consult worker
believ one best-run middle-
market insur broker organ growth
respond better price econom
environ growth along good
expens disciplin allow continu
margin improv acquisit remain
attract avenu growth above-averag
dividend yield attract sustain
invest incom
gain book sale
chang acquisit earn out/oth
earn incom tax
provis incom tax
earn incom tax
provis incom tax
estimate
organ growth fee
bofa merril lynch global research estim compani document
earn incom tax
provis incom tax
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
bofa merril lynch global research estim compani document
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
compani document bofa merril lynch global research estim
tabl arthur gallagh risk manag corpor
earn incom tax
provis incom tax
organ growth fee
earn incom tax
provis incom tax
compani document bofa merril lynch global research estim
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
bofa merril lynch global research estim compani document
po base cash ep premium compar
compani see justifi given better-than-expect growth
opportun driven success on-going strategi averag organ
growth oper leverag allow on-going margin improv lead
double-digit ep growth next sever year downsid risk price
object softer property-casualty price built expect
poor integr one sever acquisit lower industry-wid claim frequenc
hurt claim manag busi rise unemploy could hurt
claim manag busi expos worker compens residu
environment tax liabil relat synthet coal invest chang
health care regul impact benefit broke busi chang
dividend strategi compani
alison jacobowitz herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
